Lutterotti, A; Kuenz, B; Khalil, M; Gredler, V; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T; Reindl, M.
Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment
MULT SCLER. 2006; 12: S66-S66.
[Poster]
Web of Science